Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Schmitz

Showing results (281-290 of 385) with videos related to

Pageof 39
Sort By:
Leukemia & Lymphoma|March 29, 2021
Allogeneic hematopoietic stem cell transplantation for therapy-related myeloid neoplasms following treatment of a lymphoid malignancyDaniela V Wenge, Klaus Wethmar, Jan-Henrik Mikesch, et al.
Bone Marrow Transplantation|May 17, 2020
Changes in patients population and characteristics of hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma: an analysis of the Lymphoma Working Party of the EBMTAnna Sureda, Sonja Genadieva Stavrik, Ariane Boumendil, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 17, 2018
The Impact of Advanced Patient Age on Mortality after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma: A Retrospective Study by the European Society for Blood and Marrow Transplantation Lymphoma Working PartyCharalampia Kyriakou, Ariane Boumendil, Herve Finel, et al.
Haematologica|July 6, 2005
Development of leukemia in donor cells after allogeneic stem cell transplantation--a survey of the European Group for Blood and Marrow Transplantation (EBMT)Bernd Hertenstein, Lothar Hambach, Andrea Bacigalupo, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 24, 2017
Comparing three-year extension of early intervention service to regular care following two years of early intervention service in first-episode psychosis: a randomized single blind clinical trialAshok Malla, Ridha Joober, Srividya Iyer, et al.
Early Intervention in Psychiatry|November 8, 2021
Adapting, updating and translating the Social Functioning Scale to assess social, recreational and independent functioning among youth with psychosis in diverse sociocultural contextsNicole Pawliuk, Ashok Malla, Greeshma Mohan, et al.
Leukemia & Lymphoma|December 23, 2020
Identification of a miRNA based model to detect prognostic subgroups in patients with aggressive B-cell lymphomaCarmen Nordmo, Gunther Glehr, Michael Altenbuchinger, et al.
Blood|April 2, 2020
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPIAmy S Ruppert, Jesse G Dixon, Gilles Salles, et al.
Blood|February 26, 2004
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHLMichael Pfreundschuh, Lorenz Trümper, Marita Kloess, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2008
High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow TransplantationCharalampia Kyriakou, Carmen Canals, Anthony Goldstone, et al.
Pageof 39

Showing results (281-290 of 385) with videos related to

Sort By:
Pageof 39
Leukemia & Lymphoma|March 29, 2021
Allogeneic hematopoietic stem cell transplantation for therapy-related myeloid neoplasms following treatment of a lymphoid malignancyDaniela V Wenge, Klaus Wethmar, Jan-Henrik Mikesch, et al.
Bone Marrow Transplantation|May 17, 2020
Changes in patients population and characteristics of hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma: an analysis of the Lymphoma Working Party of the EBMTAnna Sureda, Sonja Genadieva Stavrik, Ariane Boumendil, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 17, 2018
The Impact of Advanced Patient Age on Mortality after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma: A Retrospective Study by the European Society for Blood and Marrow Transplantation Lymphoma Working PartyCharalampia Kyriakou, Ariane Boumendil, Herve Finel, et al.
Haematologica|July 6, 2005
Development of leukemia in donor cells after allogeneic stem cell transplantation--a survey of the European Group for Blood and Marrow Transplantation (EBMT)Bernd Hertenstein, Lothar Hambach, Andrea Bacigalupo, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 24, 2017
Comparing three-year extension of early intervention service to regular care following two years of early intervention service in first-episode psychosis: a randomized single blind clinical trialAshok Malla, Ridha Joober, Srividya Iyer, et al.
Early Intervention in Psychiatry|November 8, 2021
Adapting, updating and translating the Social Functioning Scale to assess social, recreational and independent functioning among youth with psychosis in diverse sociocultural contextsNicole Pawliuk, Ashok Malla, Greeshma Mohan, et al.
Leukemia & Lymphoma|December 23, 2020
Identification of a miRNA based model to detect prognostic subgroups in patients with aggressive B-cell lymphomaCarmen Nordmo, Gunther Glehr, Michael Altenbuchinger, et al.
Blood|April 2, 2020
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPIAmy S Ruppert, Jesse G Dixon, Gilles Salles, et al.
Blood|February 26, 2004
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHLMichael Pfreundschuh, Lorenz Trümper, Marita Kloess, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2008
High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow TransplantationCharalampia Kyriakou, Carmen Canals, Anthony Goldstone, et al.
Pageof 39